Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

24 Apr 2004Dr Andrew G Renehan, PhD, Marcel Zwahlen, PhD, Prof Christoph Minder, PhD, Sarah T O'Dwyer, MD, Prof Stephen M Shalet, MD, Prof Matthias Egger, MD

Circulating concentrations of IGF-I and IGFBP-3 are associated with an increased risk of common cancers, but associations are modest and vary between sites.

Systematic review
2 effects
10746 subjects

Reported Outcomes

DeterminantsOutcomeDetails

Insulin-like Human Growth Hormone (IGF-1) Endocrine outcome
Insulin-like Human Gr...
Endocrine system

Prostate Cancer Reproductive outcome
Increased risk of Prostate Cancer
Reproductive system

High evidence
49.0%

Insulin-like Human Growth Hormone (IGF-1) Endocrine outcome
Insulin-like Human Gr...
Endocrine system

Breast Cancer Reproductive outcome
Increased risk of Breast Cancer
Reproductive system

High evidence
65.0%